Daily News

Ravi Suppiah, MBChB, MD, FRACP, and members of the steering committee responsible for overseeing the update will explain the need for revised classification criteria, highlight the changes to the classification criteria, and demonstrate how to apply the criteria appropriately.

“We now know of antibody-mediated diseases that did not have an explanation and were probably misdiagnosed previously in many cases and not appropriately treated,” said Tracey Cho, MD.

Across different populations of Native Americans tend to have higher frequency of some rheumatic diseases, said Judith A. James, MD, PhD, including rheumatoid arthritis and systemic lupus erythematosus.

Jon T. Giles, MD, MPH, one of the session presenters, will discuss adiposity and inflammation in rheumatoid arthritis.

“Rheumatology professionals need to be online because that is where their patients are,” said LeAnna J. Carey, MBA.

Andrea Kalus, MD, will review and update practicing rheumatologists on common, and not so common, lupus-associated skin diseases and how to approach diagnosis and treatment.

“The past few years have seen tremendous advances brought to our practices by clinically available unbiased DNA sequencing approaches,” Jordan S. Orange, MD, PhD, said. “These changes and what they hold for our patients are important to consider.”

“Takayasu is a rare disease, but every rheumatologist can expect to see these patients in their practice,” said Amr H. Sawalha, MD. “Because it is so rare, three or four patients per million, this kind of international collaboration is essential.”

The ACR, the Indian Rheumatology Association (IRA), and the Pan American League of Associations for Rheumatology (PANLAR) are pleased to announce the recipients of awards in the International Visiting Fellows Exchange Program: Ignacio Gandino, MD, of Buenos Aires, Argentina; and Sonal Mehra, MBBS, of New…